IRIS Institutional Research Information System - OPENBS Open Archive UniBS

COLLO, LUIGIA RINALDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.757
AS - Asia 3.138
EU - Europa 2.855
SA - Sud America 611
Continente sconosciuto - Info sul continente non disponibili 386
AF - Africa 68
OC - Oceania 13
Totale 12.828
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.643
SG - Singapore 1.119
CN - Cina 1.088
PL - Polonia 677
UA - Ucraina 600
BR - Brasile 504
IT - Italia 398
DE - Germania 289
HK - Hong Kong 282
VN - Vietnam 207
FR - Francia 199
FI - Finlandia 190
GB - Regno Unito 149
TR - Turchia 103
RU - Federazione Russa 94
BD - Bangladesh 93
IE - Irlanda 93
IN - India 93
CA - Canada 60
AR - Argentina 44
CH - Svizzera 39
BE - Belgio 28
ID - Indonesia 27
MX - Messico 25
IQ - Iraq 22
NL - Olanda 21
EC - Ecuador 20
NG - Nigeria 20
AT - Austria 19
IR - Iran 16
ZA - Sudafrica 15
CZ - Repubblica Ceca 14
AU - Australia 12
ES - Italia 12
SE - Svezia 12
JP - Giappone 11
MA - Marocco 11
CL - Cile 10
CO - Colombia 10
EU - Europa 9
KZ - Kazakistan 9
SA - Arabia Saudita 9
PE - Perù 8
VE - Venezuela 8
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
JO - Giordania 6
PK - Pakistan 6
EG - Egitto 5
ET - Etiopia 5
PA - Panama 5
TT - Trinidad e Tobago 5
DZ - Algeria 4
JM - Giamaica 4
KE - Kenya 4
KR - Corea 4
OM - Oman 4
HN - Honduras 3
LB - Libano 3
LT - Lituania 3
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
SI - Slovenia 2
TM - Turkmenistan 2
TN - Tunisia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
KI - Kiribati 1
LV - Lettonia 1
PH - Filippine 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 12.449
Salva come PNG Salva come JPEG
Città #
Warsaw 675
Singapore 634
Ashburn 499
Woodbridge 481
Fairfield 463
Jacksonville 439
Houston 287
Hong Kong 278
Ann Arbor 240
Beijing 235
Cambridge 231
Chandler 229
San Jose 228
Seattle 204
The Dalles 195
Princeton 177
Wilmington 176
Nanjing 139
New York 139
Brescia 104
Dearborn 98
Lauterbourg 95
Helsinki 93
Dublin 92
Columbus 90
Istanbul 85
Los Angeles 83
Des Moines 67
Ho Chi Minh City 65
Nanchang 54
Buffalo 53
Council Bluffs 53
Munich 51
São Paulo 49
Milan 45
Hanoi 40
Moscow 38
Santa Clara 38
Hebei 37
Jiaxing 37
Shenyang 37
Dallas 36
Basel 35
Dong Ket 34
Changsha 32
London 28
San Francisco 28
Tianjin 28
Chicago 27
Orem 27
Shanghai 27
Jinan 26
Rio de Janeiro 25
Brussels 24
San Donà Di Piave 24
San Diego 22
Abuja 20
Turku 20
Redondo Beach 19
Toronto 19
Jakarta 18
Phoenix 18
Brooklyn 17
Montreal 16
Pune 16
Rome 16
Lancaster 15
Leawood 15
Hangzhou 14
Hefei 14
Kunming 14
San Mateo 14
Atlanta 13
Frankfurt am Main 13
Boston 12
Brno 12
Guangzhou 12
Teramo 12
Verona 12
Zhengzhou 12
Boardman 11
Denver 11
Mexico City 11
Guayaquil 10
Lanzhou 10
Manchester 10
Ningbo 10
Tokyo 10
Brasília 9
Charlotte 9
Haiphong 9
Johannesburg 9
Norwalk 9
Taizhou 9
Vienna 9
Ardabil 8
Augusta 8
Baghdad 8
Belo Horizonte 8
Changchun 8
Totale 8.325
Salva come PNG Salva come JPEG
Nome #
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 327
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 322
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 280
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 266
Ketamine enhances structural plasticity in human dopaminergic neurons: Possible relevance for treatment-resistant depression 221
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 193
Pluripotent Stem Cell Based Cultures to Study Key Aspects of Human Cerebral Cortex Development 186
Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels 180
Structural plasticity induced by ketamine in human dopaminergic neurons as mechanism relevant for Treatment-Resistant Depression 180
(2 R,6 R)-Hydroxynorketamine promotes dendrite outgrowth in human inducible pluripotent stem cell-derived neurons through AMPA receptor with timing and exposure compatible with ketamine infusion pharmacokinetics in humans 173
Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine 168
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 165
A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: Focus on dopaminergic system 165
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 163
Ketamine increases the expression of GluR1 and GluR2 α-amino-3-hydroxy-5-methy-4-isoxazole propionate receptor subunits in human dopaminergic neurons differentiated from induced pluripotent stem cells 162
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling 154
An antagonist-insensitive P2X receptor expressed in epithelia and brain 153
Blockade of human P2X7 receptor function with a monoclonal antibody. 152
ATP mediated cytotoxicity in microglial cells. 151
P2X1 receptor activation in HL60 cells. 148
Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs. 148
Distictive functions of a6b4 and other integrins in epithelial cells. 147
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 144
The NMDA/D1 receptor complex as a new target in drug development 140
Ketamine effects on mammalian target of rapamycin signaling in the mouse limbic system depend on functional dopamine D3 receptors 139
Purinoceptors in the central nervous system 137
Dopamine D3 receptors are critically involved in the neurotrophic effects of cocaine and nicotine on the mouse mesencephalic dopaminergic neurons 134
Critical role of dopamine D3 receptor in structural plasticity generated by exposure to drugs of addiction in mesencephalic dopaminergic neurons 134
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 133
Tissue distribution of the P2X7 receptor 132
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 132
Alpha-synuclein aggregation in dopaminergic cells is modulated by glucose metabolism 131
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 129
A new isoform of the laminin receptor α7β1 is developmentally regulated in skeletal muscle. 128
Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation. 128
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 128
Alphα6-containing nicotinic acetylcholine receptors mediate nicotine-induced structural plasticity in mouse and human iPSC-derived dopaminergic neurons 128
Immature neuronal phenotype derived from mouse skin precursor cells differentiated in vitro. 126
D3 receptor involvement in neurotrophic effects of amphetamine and cocaine on mesencephalic dopaminergic neurons 126
Differential onset of expression of alpha7 and beta1D integrins during mouse heart and skeletal muscle development. 122
Dopamine D3 receptor and beta-2 containing nicotinic acetylcholine receptor are critical in mediating nicotine effects on dopaminergic neurons morphology 122
Attenuated acute effects of ketamine on mTOR pathway in the limbic system of dopamine D3 receptor knock-out mice 122
Cell-type specific integrin variants with alternative α chain cytoplasmic domain 120
P2X receptors: an emerging channel family. 120
Neuroadaptation mechanisms to nicotine in mesencephalic dopaminergic neurons: role of dopamine D3 receptor and nicotinic acetylcholine receptors. 119
Morphogenetic changes produced by cocaine and nicotine in mesencephalic dopaminergic neurons: role of dopamine D3 receptor 117
CRISPR targeting of human induced pluripotent stem cells (HIPSCS) for lineage tracing of HIPSCS-derived neural stem cells during cortical development in vitro 117
Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential 117
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 116
Ketamine produces structural plasticity in dopaminergic neurons via co-activation of MEK-ERK and Akt-mTOR pathways: translation from mouse primary culture to human iPSC-derived neurons 116
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 115
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 114
Dopamine-induced Erk activation in striatal neurons is mediated by a direct interaction between the D1 receptor and the tyrosine phosphatase Shp-2. 113
Neurotrophic effects of cocaine on mouse mesencephalic dopaminergic neurons are mediated by dopamine D3 receptors 113
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 113
Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. 112
The Shp-2 tyrosine phosphatase interacts with the dopamine D1 receptor and triggers D1-mediated Erk signalling in striatal neurons. 112
Nicotine produces structural plasticity of mesencephalic dopaminergic neurons via activation of Akt-mTor pathway 111
Dopamine D1R activation modulates intracellular signalling and triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 110
Ketamine produces structural plasticity in dopaminergic neurons in vitro via co-activation of MEK-ERK and Akt-mTOR pathways: role of BDNF and dopamine D3 receptor 110
Dopamine agonists produce neurotrophic effects on mesencephalic dopaminergic neurons via dopamine D3 receptor activation 109
Selective dopaminergic alpha-synuclein pathological changes following glucose deprivation "in vitro": implications for Parkinson's disease 108
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques 108
Ketamine produces structural plasticity of mouse mesencephalic dopaminergic neurons via activation of Akt-mTOR pathway: role of dopamine D3 receptor. 107
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs). 106
Effetti neurotrofici dei farmaci agonisti preferenziali D3 sui neuroni mesencefalici: implicazioni terapeutiche per la malattia di Parkinson. 106
Oxide Nanowires for Neuron Adhesion and Growth 106
Nicotine enhances the neuroplasticity of dopamine neurons: role of dopamine D3 receptors and acetylcholine nicotinic receptors. 105
Human iPS cell-derived dopaminergic neurons reveal role for D3 receptors and mTOR in induction of structural plasticity by antiparkinson DA agonists 103
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs) 101
Distinct alpha7A-beta1 and alpha7B-beta1 integrin expression patterns during mouse development: alpha7A is restricted to skeletal muscle but alpha7B is expressed in striated muscle, vasculature, and nervous system. 101
Testing drugs for structural plasticity in dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons 101
The integrin alpha6beta4 in epithelial and carcinoma cells 100
Testing the effect of dopamine agonists and of drugs of addiction on structural plasticity of dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons 100
Evidence for soluble Interleukin-2 receptor (IL-2) as immunosuppressive factor. 98
Gradient of integrin α6A expession in the myocardium during early heart development. 94
Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings 93
Nicotine enhances structural plasticity in mesencephalic dopaminergic neurons: involvement of dopamine D3 receptors and nicotinic acetylcholine receptors. 92
Long-term expansion of dopaminergic progenitors from human induced pluripotent stem cells (iPSCs) and differentiation into dopaminergic neurons in vitro and in vivo 91
Involvement of nicotinic acetylcholine receptors and dopamine D3 receptors in structural plasticity of dopaminergic neurons 90
Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro. 89
Loss of Synaptic D1 Dopamine/N-Methyl-D-aspartate Glutamate Receptor Complexes in L-DOPA-Induced Dyskinesia in the Rat. 89
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. 88
Involvement of DA D3 Receptors in Structural Neuroplasticity of Selected Limbic Brain Circuits: Possible Role in Treatment-Resistant Depression 87
Myogenic conversion of NIH3T3 cells by exogenous MyoD family members: dissociation of terminal differentiation from myotube formation. 87
Neuroprotective effects of D2/D3 agonists in an "in vitro" model of dopaminergic degeneration 86
Dopamine D3 receptors mediate the neurotrophic effects of dopaminergic agonists on mesencephalic dopaminergic neurons 84
Dopamine D3 receptors mediate the neurotrophic effects of dopaminergic agonists on mesencephalic dopaminergic neurons. 84
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. 81
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs). 80
Meccanismo molecolari e cellulari nel Morbo di Parkinson 80
Cortisol-dependent impairment of dendrite plasticity in human dopaminergic neurons derived from hiPSCs is restored by ketamine: Relevance for major depressive disorders 79
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 77
Downregulation of dopamine D1/NMDA receptor complexes in the post synaptic densities of dyskinetic rats 77
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 75
Nicotine produces neurotrophic effects on mesencephalic dopaminergic neurons: role of dopamine D3 receptors and nicotinic acetylcholine receptors 72
Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist 72
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 71
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs) 70
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 68
Totale 12.499
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.568
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022605 0 140 4 18 9 19 30 43 30 75 54 183
2022/2023627 93 3 10 54 57 187 4 64 106 0 15 34
2023/2024651 41 10 52 53 32 147 28 23 131 17 14 103
2024/20251.762 2 40 24 253 157 118 135 35 240 165 367 226
2025/20263.365 320 433 214 411 307 186 588 159 189 290 147 121
2026/2027289 211 78 0 0 0 0 0 0 0 0 0 0
Totale 12.828